CML cells are sensitive to hypoxia [84], and the critical regulator of hypoxia responses, hypoxia-inducible factor 1α (HIF1α), is essential for CML LSC survival in the BME [85]. Here, HIF1A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.